ER-α 36 modulator

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

PD-L1 expression	Hepatocellular Cancer	PD-L1 expression	Hepatocellular Cancer	SNG-162 Sensitive: C2 – Inclusion Criteria SNG-162 Sensitive : C2	SNG-162 Sensitive: C2 – Inclusion Criteria SNG-162 Sensitive : C2
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	SNG-162 Sensitive: D – Preclinical SNG-162 Sensitive : D	SNG-162 Sensitive: D – Preclinical SNG-162 Sensitive : D

Associations(2)